Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DR9Y | ISIN: US03782L1017 | Ticker-Symbol: 910
Tradegate
21.01.25
15:36 Uhr
31,890 Euro
-0,110
-0,34 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
APPIAN CORPORATION Chart 1 Jahr
5-Tage-Chart
APPIAN CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
32,07032,35007:46
32,09032,40007:42
PR Newswire
195 Leser
Artikel bewerten:
(1)

Appian Named a Leader in Everest Group's Process Orchestration Products PEAK Matrix 2024

Finanznachrichten News

LONDON, Dec. 3, 2024 /PRNewswire/ -- Appian (Nasdaq: APPN) announced today that it ranks #1 in the new report, Process Orchestration Products PEAK Matrix® Assessment 2024. According to the report, process orchestration helps business users design, manage, and monitor end-to-end business processes. The report analyses 24 technology providers across several key capabilities, including:

Appian Named a Leader in Everest Group's Process Orchestration PEAK Matrix 2024
  • Process design and execution
  • Business rules and decision management
  • Low-code/no-code user interface development
  • Monitoring & analytics interoperability

Appian received a Leader ranking in the report, indicating a strong vision to enable end-to-end process design and management through a low-code/no-code visual interface. As a Leader, Appian was also recognised for investing in generative AI capabilities, which improve employee productivity by automatically generating intelligent insights and other content to speed up workflows. Appian was the only vendor to receive the highest score in "Implementation and Support," an acknowledgment of our strong customer success offerings and deep process expertise.

According to Everest Group: "Appian aims to deliver comprehensive process automation and orchestration through its unified low-code platform. Its continued investments in generative AI, AI Skills, and Process HQ underscores its commitment toward innovation."

"Appian's modern approach to process orchestration, along with its native integrations with automation, generative AI, and process intelligence and focus on data security and privacy, are just some of the key factors that contributed to its position," says Amardeep Modi, Vice President at Everest Group.

"Appian streamlines business processes to solve our customers' most complex process automation challenges," said Malcolm Ross, SVP of Product Strategy at Appian. "The Appian Platform includes powerful AI, process orchestration, automation, and intelligence to help companies drive innovation and optimise operations. In addition, our enterprise data fabric enables organisations in regulated industries to enhance customer experience while staying compliant."

View the 2024 Process Orchestration Products PEAK Matrix® Assessment for Appian.

About Appian

Appian is a software company that orchestrates business processes. The Appian Platform empowers leaders to design, automate, and optimise important processes from start to finish. With our industry-leading platform and commitment to customer success, Appian is trusted by top organisations to drive transformational process change. For more information, visit appian.com. [Nasdaq: APPN]

Follow Appian: LinkedIn, X (Twitter)

Disclaimer
Licensed extracts taken from Everest Group's PEAK Matrix® Reports, may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group's?PEAK Matrix®?reports do not necessarily provide the full context of our research and analysis.? All research and analysis conducted by Everest Group's analysts and included in Everest Group's?PEAK Matrix®?reports is independent and no organisation has paid a fee to be featured or to influence their ranking.? To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix®.?

About Everest Group?
Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group's?PEAK Matrix®?assessments?provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the?PEAK Matrix®?to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth?content at?www.everestgrp.com.

Appian helps organizations build apps and workflows rapidly, with a low-code automation platform. Combining people, technologies, and data in a single workflow, Appian can help companies maximize their resources and improve business results. Many of the world's largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. To learn more, visit www.appian.com.

Photo - https://mma.prnewswire.com/media/2571758/DGR_Everest_PEAK_Matrix_report_social.jpg
Logo - https://mma.prnewswire.com/media/1488235/Appian_Caption_2700px_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/appian-named-a-leader-in-everest-groups-process-orchestration-products-peak-matrix-2024-302320654.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.